ArticleAesthetic plastic surgery2026
The Octopus Mastopexy: A True "Implant-First" and On-Demand Approach Based on Parenchymal Reduction.
Article in Aesthetic plastic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Simultaneous augmentation mastopexy represents one of the most demanding procedures in aesthetic breast surgery, due to the need to balance volume enhancement with tissue tightening. Traditional techniques often struggle to maintain long-term stability, frequently resulting in recurrent ptosis, increased tension on the wound closure, and higher complication and revision rates. The Octopus Mastopexy was developed as a standardized refinement of the inverted-T approach, aiming to provide a reproducible, tension-free result while ensuring reliable nipple-areolar complex vascularization. A retrospective review was conducted of patients who underwent primary or secondary augmentation mastopexy using the Octopus technique between January 2019 and January 2024, all performed by the senior author. The technique is characterized by an implant-first sequence, selective and on-demand parenchymal reduction, and multivector pillar mobilization to evenly redistribute tension across the breast mound. Patient-reported satisfaction and quality-of-life outcomes were assessed using the BREAST-Q questionnaire, administered preoperatively and again at least 12 months postoperatively. Ninety-five patients were included, with a mean age of 39.2 years and a mean implant volume of 300 cc. No major complications occurred. Minor wound dehiscence was observed in two patients and managed conservatively, while six patients required revision for recurrent glandular laxity or weight change. BREAST-Q scores improved significantly across all measured domains, including satisfaction with breasts, physical well-being, and psychosocial well-being. These findings suggest that the Octopus Mastopexy provides a safe, stable, and reproducible solution for simultaneous breast augmentation and mastopexy, improving aesthetic outcomes while reducing tension-related complications and revision rates.Level of Evidence V This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.